H.R. 1672 · 119th Congress (2025–2027)
Maintaining Investments in New Innovation Act
This bill requires drug products with genetically targeted technology to have had market approval for at least 11 years in order to qualify for the Medicare Drug Price Negotiation Program. (The program requires the Centers for Medicare & Medicaid Services to negotiate the prices of certain prescription drugs under Medicare beginning in 2026. Among other requirements, drugs must have had market approval for at least 7 years (for drug products) or 11 years (for biologics) to qualify for negotiation.)
Show official title
To amend title XI of the Social Security Act to protect access to genetically targeted technologies.
Referred to committee
Latest actionReferred to committee
This bill’s path
This is H.R. 1672’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
- Sponsor
- Rep. Donald G. Davis (D-NC-1)
- Cosponsors
51 cosponsors
13 original · 38 later
44 R · 7 D
- Rep. Rick W. Allen (R-GA-12)· Original · Feb 27, 2025
- Rep. Aaron Bean (R-FL-4)· Original · Feb 27, 2025
- Rep. Dan Crenshaw (R-TX-2)· Original · Feb 27, 2025
- Rep. Josh Gottheimer (D-NJ-5)· Original · Feb 27, 2025
- Rep. Richard Hudson (R-NC-9)· Original · Feb 27, 2025
- Rep. John Joyce (R-PA-13)· Original · Feb 27, 2025
- Rep. Joseph D. Morelle (D-NY-25)· Original · Feb 27, 2025
- Rep. Blake D. Moore (R-UT-1)· Original · Feb 27, 2025
- Rep. Mariannette Miller-Meeks (R-IA-1)· Original · Feb 27, 2025
- Rep. Scott H. Peters (D-CA-50)· Original · Feb 27, 2025
- Rep. Claudia Tenney (R-NY-24)· Original · Feb 27, 2025
- Rep. Beth Van Duyne (R-TX-24)· Original · Feb 27, 2025
- Rep. Rudy Yakym III (R-IN-2)· Original · Feb 27, 2025
- Rep. Neal P. Dunn (R-FL-2)· Later · Mar 27, 2025
- Rep. Kevin Hern (R-OK-1)· Later · Apr 9, 2025
- Rep. Mike Carey (R-OH-15)· Later · Apr 10, 2025
- Rep. Jefferson Shreve (R-IN-6)· Later · May 9, 2025
- Rep. August Pfluger (R-TX-11)· Later · May 13, 2025
- Rep. Pete Sessions (R-TX-17)· Later · Jun 4, 2025
- Rep. Addison P. McDowell (R-NC-6)· Later · Jun 10, 2025
- Rep. Mike Kelly (R-PA-16)· Later · Sep 2, 2025
- Rep. Charles J. "Chuck" Fleischmann (R-TN-3)· Later · Sep 17, 2025
- Rep. Nicole Malliotakis (R-NY-11)· Later · Sep 30, 2025
- Rep. Daniel Meuser (R-PA-9)· Later · Sep 30, 2025
- Rep. Brittany Pettersen (D-CO-7)· Later · Sep 30, 2025
- Rep. Troy Balderson (R-OH-12)· Later · Oct 3, 2025
- Rep. Tim Moore (R-NC-14)· Later · Oct 17, 2025
- Rep. Ken Calvert (R-CA-41)· Later · Oct 31, 2025
- Rep. Chuck Edwards (R-NC-11)· Later · Oct 31, 2025
- Rep. John R. Moolenaar (R-MI-2)· Later · Oct 31, 2025
- Rep. Randy K. Weber, Sr. (R-TX-14)· Later · Oct 31, 2025
- Rep. Vince Fong (R-CA-20)· Later · Nov 4, 2025
- Rep. Brian Jack (R-GA-3)· Later · Nov 10, 2025
- Rep. Nathaniel Moran (R-TX-1)· Later · Nov 17, 2025
- Rep. Mike Haridopolos (R-FL-8)· Later · Nov 21, 2025
- Rep. Thomas H. Kean, Jr. (R-NJ-7)· Later · Nov 21, 2025
- Rep. Laurel M. Lee (R-FL-15)· Later · Nov 21, 2025
- Rep. Ashley Hinson (R-IA-2)· Later · Dec 4, 2025
- Rep. Kevin Mullin (D-CA-15)· Later · Dec 9, 2025
- Rep. Michael Lawler (R-NY-17)· Later · Jan 13, 2026
- Rep. Andy Barr (R-KY-6)· Later · Mar 20, 2026
- Rep. Gus M. Bilirakis (R-FL-12)· Later · Apr 15, 2026
- Rep. Nicholas A. Langworthy (R-NY-23)· Later · Jun 18, 2026
- Rep. Adrian Smith (R-NE-3)· Later · Jun 18, 2026
- Rep. Lloyd Smucker (R-PA-11)· Later · Jun 18, 2026
- Rep. Gabe Evans (R-CO-8)· Later · Jun 25, 2026
- Rep. Earl L. "Buddy" Carter (R-GA-1)· Later · Aug 10, 2026
- Rep. Jared Moskowitz (D-FL-23)· Later · Aug 10, 2026
- Rep. Brian K. Fitzpatrick (R-PA-1)· Later · Aug 27, 2026
- Rep. Vicente Gonzalez (D-TX-34)· Later · Sep 4, 2026
- Rep. Michael A. Rulli (R-OH-6)· Later · Sep 24, 2026
- Policy area
- Health
- Subjects
- Genetics
- Medicare
- Prescription drugs
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in House
Document: Introduced in House
Sources
- Congress.gov actionIntro-H
- Library of Congress
- Latest
Referred to committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sources
- Congress.gov action
- House floor actions
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House |
Titles (2)
Maintaining Investments in New Innovation Act
Display title, Short title · Introduced in House
To amend title XI of the Social Security Act to protect access to genetically targeted technologies.
Official title · Introduced in House